Company Filing History:
7 out of 505 
2 out of 894 
Years Active: 2017-2022
Title: The Innovative Contributions of Andrew Placzek
Introduction
Andrew Placzek is a notable inventor based in Portland, OR (US), recognized for his significant contributions to the field of neurodegenerative diseases. With a total of 7 patents to his name, Placzek has made strides in developing methods for treating conditions associated with myelination.
Latest Patents
Among his latest patents, Placzek has focused on the use of sobetirome in the treatment of myelination diseases. His work describes methods for treating subjects who are at risk of developing neurodegenerative diseases or conditions linked to demyelination, insufficient myelination, or underdevelopment of the myelin sheath. The methods include the administration of a therapeutically effective amount of sobetirome or a pharmaceutically acceptable salt thereof. Additionally, he has disclosed ester derivatives of sobetirome that enhance central nervous system distribution.
Career Highlights
Placzek has worked with prominent institutions such as Oregon Health & Science University and the United States Government as represented by the Department of Veterans Affairs. His work in these organizations has allowed him to contribute to significant advancements in medical research and treatment methodologies.
Collaborations
Some of his notable coworkers include Thomas S. Scanlan and Tapasree Banerji, who have collaborated with him on various projects aimed at improving treatment options for neurodegenerative diseases.
Conclusion
Andrew Placzek's innovative work and dedication to advancing medical science have made a lasting impact in the field of neurodegenerative disease treatment. His patents and collaborations reflect his commitment to improving the lives of those affected by these conditions.